TCT-658 Do Drug Eluting Stents Improve Survival in All Comers?

After adjusting for baseline characteristics such as age, sex, race, diabetes, hypertension, renal disease, anemia, cancer, cerebrovascular disease and left ventricular dysfunction there was a survival benefit associated with DES ; the hazard ratios for total mortality and cardiovascular mortality w...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 60; no. 17; pp. B191 - B192
Main Authors Vagaonescu, Tudor, Deng, Yingzi, Moreyra, Abel, Kostis, John
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 23.10.2012
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Drug therapy
Heart attacks
Internal Medicine
Mortality
Online AccessGet full text

Cover

More Information
Summary:After adjusting for baseline characteristics such as age, sex, race, diabetes, hypertension, renal disease, anemia, cancer, cerebrovascular disease and left ventricular dysfunction there was a survival benefit associated with DES ; the hazard ratios for total mortality and cardiovascular mortality were 0.74 (95% CI 0.70 to 0.78; p<0.0001) and 0.58 (95% CI 0.53 to 0.63; p<0.0001) respectively.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.08.695